Skip Nav Destination
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies
Comparison of idarubicin + ara-C–, fludarabine + ara-C–, and topotecan + ara-C–based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings
Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy
Autologous stem cell transplantation for HIV-associated lymphoma
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial
Neonatal-onset hereditary coproporphyria with male pseudohermaphrodism
Issue Archive
December 15 2001
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation
Clinical Trials & Observations
Jan Storek,Ansamma Joseph,German Espino,Monja A. Dawson,Daniel C. Douek,Keith M. Sullivan,Mary E. D. Flowers,Paul Martin,George Mathioudakis,Richard A. Nash,Rainer Storb,Frederick R. Appelbaum,David G. Maloney
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Peter I. Croucher,Claire M. Shipman,Jennifer Lippitt,Mark Perry,Kewal Asosingh,Anja Hijzen,Alex C. Brabbs,Edwin J. R. van Beek,Ingunn Holen,Timothy M. Skerry,Colin R. Dunstan,Graham R. Russell,Ben Van Camp,Karin Vanderkerken
REVIEW ARTICLES
CHEMOKINES
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
Paul Proost,Evemie Schutyser,Patricia Menten,Sofie Struyf,Anja Wuyts,Ghislain Opdenakker,Michel Detheux,Marc Parmentier,Christine Durinx,Anne-Marie Lambeir,Johan Neyts,Sandra Liekens,Prabhat C. Maudgal,Alfons Billiau,Jo Van Damme
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies
Clinical Trials & Observations
Gérard Socié,Reginald A. Clift,Didier Blaise,Agnès Devergie,Olle Ringden,Paul J. Martin,Mats Remberger,H. Joachim Deeg,Tapani Ruutu,Mauricette Michallet,Keith M. Sullivan,Sylvie Chevret
Comparison of idarubicin + ara-C–, fludarabine + ara-C–, and topotecan + ara-C–based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts
Clinical Trials & Observations
Elihu H. Estey,Peter F. Thall,Jorge E. Cortes,Francis J. Giles,Susan O'Brien,Sherry A. Pierce,Xuemei Wang,Hagop M. Kantarjian,Miloslav Beran
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings
Clinical Trials & Observations
Florian Weissinger,Brenda M. Sandmaier,David G. Maloney,William I. Bensinger,Ted Gooley,Rainer Storb
Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group
Clinical Trials & Observations
Hajime Kawasaki,Keiichi Isoyama,Mariko Eguchi,Shigeyoshi Hibi,Naoko Kinukawa,Yoshiyuki Kosaka,Takanori Oda,Megumi Oda,Shin-ichiro Nishimura,Masue Imaizumi,Takayuki Okamura,Teruaki Hongo,Hiroji Okawa,Shuki Mizutani,Yasuhide Hayashi,Ichiro Tsukimoto,Nanao Kamada,Eiichi Ishii
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
Clinical Trials & Observations
Issa F. Khouri,Rima M. Saliba,Sergio A. Giralt,Ming-Sheng Lee,Grace-Julia Okoroji,Fredrick B. Hagemeister,Martin Korbling,Anas Younes,Cindy Ippoliti,James L. Gajewski,Peter McLaughlin,Paolo Anderlini,Michele L. Donato,Fernando F. Cabanillas,Richard E. Champlin
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
Clinical Trials & Observations
David A. Roth,Craig M. Kessler,K. John Pasi,Bonita Rup,Suzanne G. Courter,Karen L. Tubridy,for the Recombinant Factor IX Study Group
GENE THERAPY
Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors
Stefano Indraccolo,Sonia Minuzzo,Francesca Roccaforte,Rita Zamarchi,Walter Habeler,Laura Stievano,Valeria Tosello,Dieter Klein,Walter H. Günzburg,Giuseppe Basso,Luigi Chieco-Bianchi,Alberto Amadori
HEMATOPOIESIS
Human granulocyte-macrophage colony-stimulating factor (hGM-CSF) stimulates primitive and definitive erythropoiesis in mouse embryos expressing hGM-CSF receptors but not erythropoietin receptors
Hiroaki Hisakawa,Daisuke Sugiyama,Ichiko Nishijima,Ming-jiang Xu,Hong Wu,Kazuki Nakao,Sumiko Watanabe,Motoya Katsuki,Shigetaka Asano,Ken-ichi Arai,Tatsutoshi Nakahata,Kohichiro Tsuji
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen Aα-chain gene are not associated with the decay of the mutant mRNAs
Rosanna Asselta,Stefano Duga,Silvia Spena,Elena Santagostino,Flora Peyvandi,Gavino Piseddu,Roberto Targhetta,Massimo Malcovati,Pier Mannuccio Mannucci,Maria Luisa Tenchini
IMMUNOBIOLOGY
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load
Sharon L. Silins,Martina A. Sherritt,Jodie M. Silleri,Simone M. Cross,Suzanne L. Elliott,Mandvi Bharadwaj,Thuy T. T. Le,Leanne E. Morrison,Rajiv Khanna,Denis J. Moss,Andreas Suhrbier,Ihor S. Misko
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment
Mohamad Mohty,David Jarrossay,Marina Lafage-Pochitaloff,Christine Zandotti,Francine Brière,Xavier-Nicolas de Lamballeri,Daniel Isnardon,Danielle Sainty,Daniel Olive,Béatrice Gaugler
Simian immunodeficiency virus (SIV)–specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys
Jörn E. Schmitz,Ronald S. Veazey,Marcelo J. Kuroda,Daniel B. Levy,Aruna Seth,Keith G. Mansfield,Christine E. Nickerson,Michelle A. Lifton,Xavier Alvarez,Andrew A. Lackner,Norman L. Letvin
NEOPLASIA
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins
Asuman Demiroglu,E. Joanna Steer,Carol Heath,Kerry Taylor,Mark Bentley,Steven L. Allen,Prasad Koduru,Judith P. Brody,Geoffrey Hawson,Robyn Rodwell,Mary-Lou Doody,Fernando Carnicero,Andreas Reiter,John M. Goldman,Junia V. Melo,Nicholas C. P. Cross
Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells
Gerit-Holger Schernthaner,John-Hendrik Jordan,Minoo Ghannadan,Hermine Agis,Dorian Bevec,Rosa Nuñez,Luis Escribano,Otto Majdic,Martin Willheim,Christof Worda,Dieter Printz,Gerhard Fritsch,Klaus Lechner,Peter Valent
PHAGOCYTES
RED CELLS
BRIEF REPORTS
Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy
Clinical Trials & Observations
Brief Report
Thomas M. Moehler,Kai Neben,Axel Benner,Gerlinde Egerer,Fatime Krasniqi,Anthony D. Ho,Hartmut Goldschmidt
Autologous stem cell transplantation for HIV-associated lymphoma
Clinical Trials & Observations
Brief Report
Amrita Krishnan,Arturo Molina,John Zaia,Auayporn Nademanee,Neil Kogut,Joseph Rosenthal,Doni Woo,Stephen J. Forman
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial
Clinical Trials & Observations
Brief Report
Emin Kansu,Ted Gooley,Mary E. D. Flowers,Claudio Anasetti,H. Joachim Deeg,Richard A. Nash,Jean E. Sanders,Robert P. Witherspoon,Frederick R. Appelbaum,Rainer Storb,Paul J. Martin
Neonatal-onset hereditary coproporphyria with male pseudohermaphrodism
Clinical Trials & Observations
Brief Report
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals